Contact Us - QuickVue At-Home
Download Our App:

Contact Us

Logo for QuickVue At-Home OTC COVID-19 Test

Have questions? We can help.

For product-related questions, please visit our FAQs to see if our knowledge base has your answers.

Still have questions? Complete the information below and someone from QuidelOrtho will contact you.

VIEW OUR FAQS

Still have questions? Complete the information below and someone from QuidelOrtho will contact you.

    * Required Fields

    Please find on back of package. See image for example.

    Lot number is located below the barcode on the back of product package.

    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    QuickVue At-Home OTC COVID-19 Test in box Product questions?
    View our FAQs »

    The QuickVue At-Home OTC COVID-19 Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2.

    This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 14 years or older or adult-collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first six days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. The QuickVue At-Home OTC COVID-19 Test does not differentiate between SARS-CoV and SARS-C0V-2.

    *In the USA, this product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

    Partners of:

    • San Diego Padres logo
      San Diego Padres
    • San Diego Loyal logo
      San Diego Loyal
    • Chicago Blackhawks logo
      Chicago Blackhawks
    • New York Jets logo
      New York Jets
    • Los Angeles Rams logo
      Los Angeles Rams

    Quick Links

    Contact Us

    QuidelOrtho
    9975 Summers Ridge Road
    San Diego, CA 92121, USA
    MON – FRI 8am to 8pm EST

    FOLLOW US

    QuidelOrtho:
    QuickVue At-Home:
    Careers

    Legal Notice

    Copyright ©2023 QuidelOrtho Corporation. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to QuidelOrtho, its subsidiaries or affiliates. No use of any QuidelOrtho trademark, trade name, or trade dress in this site may be made without the prior written authorization of QuidelOrtho, except to identify the product or services of the company. By accessing, browsing and/or using this website, you acknowledge that you have read, understood, and agree to be bound by QuidelOrtho’s Website Terms and Conditions, Privacy Notice and to comply with all applicable laws and regulations. If you do not agree to these terms, do not use the website. Additionally, this website contains information on products that is targeted to many different audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for your accessing such information that may not comply with any legal process, regulation, registration, or usage in the country of your origin.